Single Market of EAEU - opportunities for pharma
Common regulatory setting and common market for medicines have…
Tecentriq needs revision
Roche and NICE cannot agree again, this time about the Tecentriq…
FDA approved Idhifa
Thanks to the FDA’s accelerated approval Tuesday of Idhifa…
Vaccines boost sales
For three of the world’s top four vaccine companies, sales…
Pfizer and Astellas refused to conduct further research of Xtandi
Pfizer and its partner Astellas refused to test breast cancer…
UDG invests in the world trends of the pharmaceutical market
A specialist in rare disease drug launches, Cambridge BioMarketing…